The ROS1ders Announces Recipients of 2024 ROS1+ Cancer Innovation Awards
Txylo.com/10309619
Trending...
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
- Last Call - Submit Your Proposal for the 2025 OpenSSL Conference in Prague
- Anern Shines at SOLAR AFRICA Kenya with Solar Lithium Battery Storage Technology
SACRAMENTO, Calif. - Txylo -- The ROS1ders, a global group of patients and caregivers living with ROS1+ cancer, announced the recipients of the 2024 ROS1+ Cancer Innovation Award. Funds for the awards were raised through individual contributions to The ROS1ders by patients and supporters. Each award carries a one-year, $75,000 seed grant to fund high-risk, high-reward research projects in ROS1+ cancer.
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
More on Txylo.com
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
More on Txylo.com
The recipients of the 2024 ROS1+ Cancer Innovation Awards are:
- Monte Winslow, PhD, Dmitri A. Petrov, PhD and Joel Neal, MD, PhD, Stanford University School of Medicine – Towards precision medicine for oncogenic ROS1 fusion driven lung cancer
This project will create models of each known ROS1 fusion variant and investigate how they influence cancer development and treatment responses. - Jaime Schneider, MD, PhD, Massachusetts General Hospital – Identifying Metabolic Vulnerabilities in ROS1+ Lung Cancer
This project aims to shed light on metabolic pathways that may contribute to acquired resistance to treatments for ROS1+ cancer, with the goal of identifying new targets for treatments that may prevent or treat resistance mechanisms.
More on Txylo.com
- Sploot Vets and DeepScan Launch Exclusive Regional U.S. Partnership to Bring Breakthrough Pet DNA Test to Market
- Virtual Valor to Release Terrance Bell's "Party Outside"
- Texas: Governor Abbott Announces Over $262,900 Job Training Grant For Workforce Solutions Lower Rio Grande Valley
- As Sober.Buzz Community Explodes It's Growth Globally it is Announcing "Spreading the Good BUZZ" Podcast Hosted by Josh Case Debuting July 7th
- Certiport Names 2025 Microsoft Office Specialist U.S. National Champions
About The ROS1ders
The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 2000 people from over 50 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaborations with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
About ROS1+ Cancer
- ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer. The incidence is thought to be similar in other types of cancer.
- Biomarker testing for ROS1 fusions is recommended in guidelines for non-small cell lung cancer, but few other cancers, yet.
- Patients typically have adenocarcinoma NSCLC, a younger age than the average NSCLC patient, and no smoking history (a smoking history should not exclude patients from biomarker testing or targeted therapies).
- Oral targeted therapies are the recommended first-line treatment for metastatic ROS1+ NSCLC and have increased the survival of patients by years. However, these drugs eventually stop working due to acquired resistance. The mechanisms of resistance are not well understood.
More on Txylo.com
- Coming Soon: The Cottages at Powell Park Offer a Rare Blend of Charm, Convenience, and Community in Raleigh
- Governor Abbott Appoints Five To Texas Historical Commission
- CredHub and All County Property Management Franchise Corp. Partner to Empower Franchisees with Rental Payment Credit Reporting Solutions
- Pregis Shares 2024 Sustainability Report Highlighting Progress in Circular Product Innovation, Emissions Accountability, and Global Impact
- Carbliss Expands Again, Launches in Houston and Tennessee Markets
Source: The ROS1ders, Inc.
0 Comments
Latest on Txylo.com
- AI changes cryptocurrency market trading, TWL Miner launches new 1-day contract, giving away over $1 million
- A Global First: NaturismRE™ Launches the Global Urgency Index
- 14th CryptoSuper500 Report Releases: Bitcoin's Evolution into a Global Supercomputer
- Ross Toohey named Managing Director in Chesterfield, Missouri
- High Profile Gateway Race Events With Strong Brand Exposure Plus Sponsorship in Female Motorsports; $100 Million Financing Unlocked: Lottery.com
- ASI Accelerates iMIS® Innovation by Acquiring CSI's Product Suite and Expert Team
- RBL LLC welcomes James Watson to board of directors
- Leoguar Bike Debuts Lightweight Ebike Helmets for Commuters and Casual Riders
- Texas: Governor Abbott Signs Property Tax Relief Laws In Denton
- Texas Summer Music & Arts Fest
- Governor Abbott Announces Over $910,000 In Career Training Grants For East Texas Schools
- Mission Wealth Reinforces Commitment to Women Investors with Expert-Led, Inclusive Financial Guidance
- United Heritage Credit Union Partners with Breast Cancer Resource Center
- PUSHERMAN- – Best Feature Documentary Official Winner at NYC and London Festivals
- Governor Abbott Announces Bandera Designated Music Friendly Texas Certified Community
- Female Motorsports Sponsorship & Expansion; Acquisition Agreement of UAE-Based Sports Incubator by Online Lottery & Sports Game Provider: Lottery.com
- Calling All Job Seekers, Career Changers & Students
- Global Court Momentum Builds Against Forced Psychiatry; CCHR Urges U.S. Reform
- Cosmos Medical Management Enhances Coding Accuracy with Expert-Led Services
- Integris Composites Joins Paris Air Show at USA Pavilion